Loading…
SeaStar Medical Holding Corporation is projected to rise to $4.34 by 2027, a +36% move from its current price of $3.20. ICU is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.05 | $3.20 | $3.34 | +0.02% |
| Aug 6 | $3.00 | $3.20 | $3.41 | +0.04% |
| Aug 7 | $2.96 | $3.20 | $3.46 | +0.06% |
| Aug 8 | $2.92 | $3.20 | $3.50 | +0.08% |
| Aug 9 | $2.89 | $3.20 | $3.54 | +0.10% |
| Aug 10 | $2.86 | $3.20 | $3.57 | +0.12% |
| Aug 11 | $2.84 | $3.20 | $3.60 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.84 | $3.20 | $3.60 | +0.14% |
| Week 2 | $2.71 | $3.20 | $3.79 | +0.28% |
| Week 3 | $2.61 | $3.21 | $3.94 | +0.43% |
| Week 4 | $2.53 | $3.21 | $4.08 | +0.57% |
| Week 5 | $2.46 | $3.22 | $4.20 | +0.71% |
| Week 6 | $2.41 | $3.22 | $4.32 | +0.85% |
| Week 7 | $2.35 | $3.23 | $4.42 | +1.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SeaStar Medical Holding Corporation is a commercial-stage healthcare company focused on therapies to reduce hyperinflammation. Its portfolio includes the selective cytopheretic device (SCD), a disease-modifying device that neutralizes over-active immune cells to stop the cytokine storm, and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury due to sepsis. The company also develops NEUTRALIZE-AKI, an SCD therapy in clinical trials for adults, along with other products in areas such as cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease.
SeaStar Medical was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical operates in the healthcare sector with a focus on therapies for critical inflammation and organ protection. Its product portfolio targets complex renal and cardiovascular conditions, reflecting a strategic emphasis on disease-modifying approaches for hyperinflammation.
SeaStar Medical Holding Corporation (ICU) is a healthcare company with a current price of $3.25 and a market capitalization of $12.99M. It ranks 5005 by market cap in the universe of listed assets.
The price outlook per the year-by-year forecast shows subtle to moderate upside starting in 2027, with 2027 avg $4.53 and 2028 avg $5.01, and continuing through 2029 at avg $5.23. The forecast then develops more significant upside, with 2030 avg $5.06 and 2031 avg $4.62, 2032 avg $5.44, and 2033 avg $7.01, culminating in strong long-term gains as shown by 2040 avg $12.73 and 2050 avg $16.19.
Overall, the long-range view points to bulls in the later years, with a long-run avg price climbing to the high single digits and into double digits by 2040–2050, accompanied by notable ROI figures in the forecast.
A major floor 49.0% below — a decisive break under it would weaken the trend.
The nearest floor, 6.7% below — buyers have tended to step in here.
The nearest ceiling, 59.0% above — a clean break opens room to run.
A major ceiling 82.5% above — clearing it would confirm fresh momentum.
Key ICU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.31 | Sell | $3.32 | Sell |
| MA 10 | $3.57 | Sell | $3.55 | Sell |
| MA 20 | $4.14 | Sell | $3.77 | Sell |
| MA 50 | $3.70 | Sell | $3.80 | Sell |
| MA 100 | $3.70 | Sell | $3.79 | Sell |
| MA 200 | $3.54 | Sell | $5.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.27 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -114.26 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | -32.25 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | -0.54 | Sell |
| Ultimate (7,14,28) | 8.69 | Buy |
| Momentum (10) | -0.87 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 3.08 | Buy |
| ADX (14) | 23.26 | Sell |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 is 30, with the short-term moving averages at SMA50 $3.73 and SMA200 $3.57.
The asset is trading within a defined 30-day range from $2.37 to $4.45, with a nearby support level at $2.98 and a resistance level at $5.08. This setup suggests near-term price action could test the lower bound or approach the resistance in a range-bound pattern.
Annualized volatility is high at 90%, signaling elevated price swings over time.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.21 | $3.20 | $4.38 | 0% | Neutral | |
| $3.26 | $4.34 | $6.22 | +36% | Bullish | |
| $3.41 | $4.77 | $7.24 | +49% | Bullish | |
| $3.47 | $5.07 | $8.03 | +59% | Bullish | |
| $3.20 | $4.85 | $7.97 | +52% | Bullish | |
| $2.84 | $4.46 | $7.55 | +39% | Bullish | |
| $3.21 | $5.22 | $9.09 | +63% | Bullish | |
| $3.88 | $6.50 | $11.61 | +104% | Bullish | |
| $4.44 | $7.68 | $14.03 | +140% | Bullish | |
| $4.43 | $7.88 | $14.70 | +147% | Bullish | |
| $5.71 | $11.69 | $23.75 | +266% | Bullish | |
| $6.95 | $15.45 | $35.46 | +384% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.21 | $3.20 | $4.03 | +0.00% |
| September 2026 | $2.65 | $3.20 | $4.00 | +0.07% |
| October 2026 | $2.67 | $3.25 | $4.14 | +1.80% |
| November 2026 | $2.80 | $3.44 | $4.44 | +5.70% |
| December 2026 | $2.70 | $3.35 | $4.38 | -2.50% |
Click any year to see its month-by-month ICU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ICU could reach as high as $4.38, with a base case around $3.20 and support toward $2.21 — roughly 0% from $3.20. Price action looks broadly range-bound.
Expect ICU to range from $3.26 to $6.22 through 2027. The $4.34 average target implies a +36% move from current prices. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ICU price prediction for 2028 points to an average of $4.77 (low $3.41, high $7.24) — a potential gain of +49% on today's $3.20. Momentum favours further upside here.
In 2029, ICU is projected to trade between $3.47 and $8.03, averaging $5.07 — a potential gain of +59% from today's $3.20. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
SeaStar Medical Holding Corporation's 2030 outlook centres on $4.85, within a $3.20 to $7.97 range. That is -4% versus the projected 2029 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2031, ICU could reach as high as $7.55, with a base case around $4.46 and support toward $2.84 — roughly +39% from $3.20. Buyers look set to stay in control over this stretch.
Expect ICU to range from $3.21 to $9.09 through 2032. The $5.22 average target implies a +63% move from current prices. That is up +17% on the projected 2031 average. Momentum favours further upside here.
The ICU price prediction for 2033 points to an average of $6.50 (low $3.88, high $11.61) — a potential gain of +104% on today's $3.20. Buyers look set to stay in control over this stretch.
In 2034, ICU is projected to trade between $4.44 and $14.03, averaging $7.68 — a potential gain of +140% from today's $3.20. That is up +18% on the projected 2033 average. Momentum favours further upside here.
SeaStar Medical Holding Corporation's 2035 outlook centres on $7.88, within a $4.43 to $14.70 range. That is up +3% on the projected 2034 average. That marks a +147% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ICU could reach as high as $23.75, with a base case around $11.69 and support toward $5.71 — roughly +266% from $3.20. Momentum favours further upside here.
Expect ICU to range from $6.95 to $35.46 through 2050. The $15.45 average target implies a +384% move from current prices. That is up +32% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ICU today (≈ 312.989045 ICU) could be worth
$4,836.56
+$3,836.56 (+384%) by 2050 · US Dollar
Based on the average projected ICU price of $15.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICUwould be worth at today's price.
$1,000 invested in ICU on Jul 31, 2025 (≈ 164.203608 ICU) would be worth
$524.63
-$475.37 (-47.5%) today · 0.52× · US Dollar
Based on a ICU entry price of $6.09 vs. today's $3.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.75 | $852 | -14.8% |
| 1 month ago | $4.86 | $657.41 | -34.3% |
| 3 months ago | $4.37 | $731.12 | -26.9% |
| 6 months ago | $2.52 | $1,267.86 | +26.8% |
| 1 year ago | $6.09 | $524.63 | -47.5% |
| All time (5.0y) ago | $2,474 | $1.29 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICU forecast.
Our base-case forecast reaches $6.40 around 2033.
Implied market cap at $6.40: $25.58M
The year-by-year forecast shows a clearly bullish drift after 2026, with each year delivering higher averages and meaningful ROIs. For 2027, the avg is $4.53 with ROI 39.5% and a bullish sentiment; 2028 shows avg $5.01 with ROI 54.1%; 2029 at avg $5.23 with ROI 60.9%. By 2030, the avg is $5.06 with ROI 55.6% and a bullish stance persists.
The forecast continues to build momentum into the mid-to-late 2030s, with 2033 avg $7.01 (ROI 115.8%), 2034 avg $8.20 (ROI 152.4%), and 2035 avg $8.30 (ROI 155.5%), all labeled Bullish.
Looking further out, 2040 shows an avg of $12.73 with ROI 291.6% and 2050 shows an avg of $16.19 with ROI 398.1%, both underscoring substantial upside potential despite expected volatility. These projections imply a pronounced long-run uptrend, albeit with high volatility and uncertainty inherent in any forecast of small-cap healthcare equities.
Note: These figures are estimates and not guarantees. Investors should consider the indicated volatility and the inherent risks before making decisions.
Tap a question to reveal the answer.
The 2030 forecast shows min $3.26, avg $5.06, max $8.46 with ROI 55.6% and a bullish outlook.
The forecast shows a bullish trajectory from 2027 onward, with 2030 avg $5.06, 2040 avg $12.73, and 2050 avg $16.19, delivering high ROI (55.6% in 2030 and up to 398.1% by 2050). However, volatility is high (annualized 90%), and these are estimates, not guarantees.
Yes. The forecast implies that by 2040 the avg price is $12.73, which would exceed $10, and by 2050 the avg is $16.19.
The current price is $3.25.
The market cap is $12.99M.
SeaStar Medical Holding Corporation Community Discussion
0Share your SeaStar Medical Holding Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.